NIP
TCON

Nicholas Investment Partners’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Nicholas Investment Partners’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-150
Closed -$340K – 332
2015
Q2 		$340K Hold
150
– – 0.02% 299
2015
Q1 		$421K Buy
+150
New +$394K 0.03% 300

Other funds holding TCON

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Nicholas Investment Partners's TCON Position: Q3 2015 in Review

Nicholas Investment Partners sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q3 2015, closing a stake of 150 shares — an estimated $340K sold.

Nicholas Investment Partners first reported a position in TCON in Q1 2015 and held it in 2 quarters. The position peaked at $421K in Q1 2015. 27 funds tracked by Wall St. Rank hold TCON as of Q3 2015.

  • Nicholas Investment Partners reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Nicholas Investment Partners sold 150 TRACON Pharmaceuticals, Inc. Common Stock shares in Q3 2015, an estimated $340K.
  • Nicholas Investment Partners first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2015 and held it in 2 quarters.
  • Nicholas Investment Partners's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $421K in Q1 2015.
  • 27 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q3 2015.

Based on Nicholas Investment Partners's 13F filing for Q3 2015, filed 17 Nov 2015.